All AI training jobs

Mercor · STEM & research

Epidemiologist — Patient Population Sizing

Listed on Mercor as “Epidemiologist - Patient Population Sizing

$150-$175/hrRemoteContractPaid in USD
ShareWhatsAppTelegramEmail

What this actually is

You design problems that stump current AI models, evaluate AI reasoning against the correct answer, write rubrics, and provide expert feedback. Often the highest-paid category because the expertise pool is small. The platform title (Epidemiologist - Patient Population Sizing) reflects the rate band and the expertise required, not the day-to-day work.

Advertisement

Can you do this on your visa?

F-2 / F-4 / F-5 / F-6: open. E-1 to E-7: needs concurrent-employment permit. D-2 / D-4 students: S-3 permit, 20 hr/week cap. D-10 / D-8: case by case.

Korean tax on USD income

First 5 years in Korea: foreign-source income only taxed if remitted into Korea. After year 5: worldwide income. Full tax guide.

Original posting from Mercor

Mercor is partnering with a biotech and pharma research team on expert human-evaluation work - creating and critiquing rubrics that analyze commercial drugs and drug-development programs. We're seeking an epidemiologist for a paid pilot, with the potential to continue as the work scales.

Responsibilities

  • Create and critique rubrics that analyze commercial drugs and drug-development programs
  • Size the patient population for a given drug or indication (prevalence, incidence, diagnosed → treated → addressable)
  • Judge whether a patient-population estimate is sound and well-sourced, and flag over- or under-counting
  • Apply this across the pilot's set of drugs and indications

Requirements

  • US-based epidemiologist
  • Familiarity with biotech/pharma development programs
  • Experience turning real-world data (claims, EHR, registries) into patient funnels
  • 5+ years practising epidemiology (graduate degree in epidemiology, biostatistics, or public health)

Engagement Details

  • Duration: Approximately 10-20 hours over a 1-2 week pilot
  • Remote - US-based

Why Participate

  • Help improve expert AI evaluation of drugs and drug-development programs
  • Recurring engagement for strong contributors

Quoted from Mercor’s public listing on 2026-09-08. We don’t edit platform copy; honest framing is in the title and the “what this actually is” block above.

Apply on Mercor